Macrophage inhibitory factor: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
← Older edit
Michal Harel (talk | contribs)
31,761 edits
No edit summary
Michal Harel (talk | contribs)
31,761 edits
No edit summary
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<StructureSection load='2ooh' size='350' side='right' caption='Structure of human macrophage inhibitory factor trimer complex with inhibitor, glycerol and sulfate (PDB entry [[2ooh]])' scene=''>
<StructureSection load='2ooh' size='350' side='right' caption='Structure of human macrophage inhibitory factor trimer complex with inhibitor, glycerol and sulfate (PDB entry [[2ooh]])' scene='55/551208/Cv/1'>
== Function ==
'''Macrophage inhibitory factor''' or '''Macrophage migration inhibitory factor''' (MIF) is an inflammatory cytokine.  '''MIF2''' or '''D-dopachrome tautomerase'''  or '''D-dopachrome decarboxylase''' is a pro-inflammatory cytokine which regulates the innate and adaptive immune response<ref>PMID:22507380</ref>.  MIF is released to the blood stream upon stimulation of white blood cells by bacterial antigens<ref>PMID:11032394</ref>. 


'''Macrophage inhibitory factor''' (MIF) is an inflammatory cytokine.  MIF is released to the blood stream upon stimulation of white blood cells by bacterial antigens.  MIF contains two different catalytic sites.  A phenylpyruvate tautomerase site is located in the N terminal.  A disulfide reductase site is located in the tetrapeptide Cys-Ala-Leu-Cys in position 57-60.
== Relevance ==
</StructureSection>
MIF plays a role in various solid and hematologic tumors<ref>PMID:19326434</ref>.  MIF is overexpressed in various tumors and is suggested to be the molecular link between chronic inflammation and cancer.  MIF has a role in skin inflammation, immune response, disease, tumorigenesis and wound healing<ref>PMID:15659324</ref>.  MIF has a role in Alzheimer disease and its inhibition may prevent the disease onset<ref>PMID:20200619</ref>.
 
== Structural highlights ==
MIF contains two different catalytic sites.  A phenylpyruvate tautomerase site is located in the N terminal.  A <scene name='55/551208/Cv/5'>disulfide reductase site is located in the tetrapeptide Cys-Ala-Leu-Cys in position 57-60</scene>. The <scene name='55/551208/Cv/6'>inhibitor binds to the pro-inflammatory tautomerase site</scene><ref>PMID:17526494</ref>. Water molecules shown as red spheres.


==3D structures of macrophage inhibitory factor==
==3D structures of macrophage inhibitory factor==
[[Macrophage inhibitory factor 3D structures]]


Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
</StructureSection>
{{#tree:id=OrganizedByTopic|openlevels=0|
 
*macrophage inhibitory factor
 
**[[1mif]] – MIF (mutant) – rat<BR />
**[[1fim]], [[1gif]], [[1gd0]], [[3djh]] – hMIF – human<BR />
**[[1cgq]], [[1p1g]], [[4etg]], [[4eui]], [[4evg]], [[4grn]], [[4gro]], [[4grp]], [[4grq]], [[4grr]], [[4gru]] – hMIF (mutant) <BR />
**[[1mff]] – mMIF (mutant) – mouse<BR />
**[[1hfo]] – MIF – ''Trichinella spiralis'' <BR />
**[[1uiz]] – MIF – ''Xenopus laevis'' <BR />
**[[2wkb]], [[2wkf]] – MIF – ''Plasmodium berghei'' <BR />
**[[3t5s]] – MIF – ''Giardia lamblia''<BR />
**[[4gum]] – MIF (mutant) – rhesus monkey<BR />
**[[4dh4]] – MIF – ''Toxoplasma gondii'' <BR />
 
*MIF complexes


**[[1mfi]], [[2gdg]] – mMIF + inhibitor <BR />
== References ==
**[[1ca7]] – hMIF + hydroxyphenylpyruvate<BR />
<references/>
**[[3ijj]] – hMIF + hydroxyphenylpyruvate + inhibitor<BR />
**[[1gcz]], [[1ljt]], [[2ooh]], [[2oow]], [[2ooz]], [[3b9s]], [[3jsf]], [[3jsg]], [[3jtu]], [[3l5p]], [[3l5r]], [[3l5s]], [[3l5t]], [[3l5u]], [[3l5v]], [[3ijg]], [[4f2k]], [[3smb]], [[3smc]], [[3wnr]], [[3wns]], [[3wnt]], [[4osf]], [[4p01]], [[4k9g]], [[4oyq]], [[4p0h]], [[4wr8]], [[4wrb]] – hMIF + inhibitor <BR />
**[[3dji]] – hMIF + tylenol<BR />
**[[3ce4]] – hMIF + PMSF<BR />
**[[3hof]] – hMIF + cafeic acid<BR />
**[[3u18]] – hMIF + Chicago sky blue<BR />
**[[3rf4]], [[3rf5]] – MIF + inhibitor – ''Ancylostoma ceylanicum''<br />
**[[4p7m]], [[4p7s]] – MIF + inhibitor – ''Plasmodium falciparum''<BR />
}}
[[Category:Topic Page]]
[[Category:Topic Page]]

Latest revision as of 12:21, 21 October 2021

Function

Macrophage inhibitory factor or Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine. MIF2 or D-dopachrome tautomerase or D-dopachrome decarboxylase is a pro-inflammatory cytokine which regulates the innate and adaptive immune response[1]. MIF is released to the blood stream upon stimulation of white blood cells by bacterial antigens[2].

Relevance

MIF plays a role in various solid and hematologic tumors[3]. MIF is overexpressed in various tumors and is suggested to be the molecular link between chronic inflammation and cancer. MIF has a role in skin inflammation, immune response, disease, tumorigenesis and wound healing[4]. MIF has a role in Alzheimer disease and its inhibition may prevent the disease onset[5].

Structural highlights

MIF contains two different catalytic sites. A phenylpyruvate tautomerase site is located in the N terminal. A . The [6]. Water molecules shown as red spheres.

3D structures of macrophage inhibitory factor

Macrophage inhibitory factor 3D structures


Structure of human macrophage inhibitory factor trimer complex with inhibitor, glycerol and sulfate (PDB entry 2ooh)

Drag the structure with the mouse to rotate

ReferencesReferences

  1. ↑ Merk M, Mitchell RA, Endres S, Bucala R. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine. 2012 Jul;59(1):10-7. doi: 10.1016/j.cyto.2012.03.014. Epub 2012 Apr 14. PMID:22507380 doi:http://dx.doi.org/10.1016/j.cyto.2012.03.014
  2. ↑ Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res. 2000 Sep;20(9):751-62. PMID:11032394 doi:http://dx.doi.org/10.1089/10799900050151012
  3. ↑ Bach JP, Deuster O, Balzer-Geldsetzer M, Meyer B, Dodel R, Bacher M. The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer. 2009 May 15;115(10):2031-40. doi: 10.1002/cncr.24245. PMID:19326434 doi:http://dx.doi.org/10.1002/cncr.24245
  4. ↑ Shimizu T. Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci. 2005 Feb;37(2):65-73. PMID:15659324 doi:http://dx.doi.org/10.1016/j.jdermsci.2004.08.007
  5. ↑ Bacher M, Deuster O, Aljabari B, Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP, Al-Abed Y, Dodel R. The role of macrophage migration inhibitory factor in Alzheimer's disease. Mol Med. 2010 Mar;16(3-4):116-21. doi: 10.2119/molmed.2009.00123. Epub 2010 Feb, 28. PMID:20200619 doi:http://dx.doi.org/10.2119/molmed.2009.00123
  6. ↑ Crichlow GV, Cheng KF, Dabideen D, Ochani M, Aljabari B, Pavlov VA, Miller EJ, Lolis E, Al-Abed Y. Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor. J Biol Chem. 2007 Aug 10;282(32):23089-95. Epub 2007 May 25. PMID:17526494 doi:http://dx.doi.org/10.1074/jbc.M701825200

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky
Retrieved from "https://proteopedia.openfox.io/wiki/index.php?title=Macrophage_inhibitory_factor&oldid=3465885"